Skip to the page

Data / Form D filings / Raptor Pharmaceutical Corp

Raptor Pharmaceutical Corp: Form D filing

Raptor Pharmaceutical Corp, a pharmaceuticals company in Novato, CA, filed a Form D with the SEC in 2010. The latest, on August 18, 2010, reports $15.1 million sold of a $15.1 million offering to 24 investors.

Find out what Raptor Pharmaceutical Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
9 COMMERCIAL BLVD, SUITE 200, Novato, CA, 94949
Phone
(415) 382-1390
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1070698

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 18, 2010New notice$15,060,163$15,060,163$024Aug 9, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas E. DaleyExecutive Officer
Todd C. ZankelExecutive Officer
Christopher M. StarrExecutive Officer, Director
Richard L. FranklinDirector
Erich W. SagerDirector
Patrice P. RiouxExecutive Officer
Llew L. KeltnerDirector
Kim R. TsuchimotoExecutive Officer
Raymond W. AndersonDirector

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Aug 16, 2010 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Raptor Pharmaceutical Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.